HK1007957A1 - 液狀藥用合劑藻酸鹽和重碳酸鉀 - Google Patents

液狀藥用合劑藻酸鹽和重碳酸鉀 Download PDF

Info

Publication number
HK1007957A1
HK1007957A1 HK98107193A HK98107193A HK1007957A1 HK 1007957 A1 HK1007957 A1 HK 1007957A1 HK 98107193 A HK98107193 A HK 98107193A HK 98107193 A HK98107193 A HK 98107193A HK 1007957 A1 HK1007957 A1 HK 1007957A1
Authority
HK
Hong Kong
Prior art keywords
potassium bicarbonate
pharmaceutical composition
liquid pharmaceutical
alginate
composition alginate
Prior art date
Application number
HK98107193A
Other languages
English (en)
Chinese (zh)
Other versions
HK1007957B (en
Inventor
Frederick Field Paul
Original Assignee
Reckitt Benckiser Healthcare (Uk) Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10770811&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1007957(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Reckitt Benckiser Healthcare (Uk) Limited filed Critical Reckitt Benckiser Healthcare (Uk) Limited
Publication of HK1007957B publication Critical patent/HK1007957B/xx
Publication of HK1007957A1 publication Critical patent/HK1007957A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK98107193A 1995-03-03 1998-06-27 液狀藥用合劑藻酸鹽和重碳酸鉀 HK1007957A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9504599.3A GB9504599D0 (en) 1995-03-03 1995-03-03 Improvements in or relating to organic compositions
GB9504599 1995-03-03

Publications (2)

Publication Number Publication Date
HK1007957B HK1007957B (en) 1999-04-30
HK1007957A1 true HK1007957A1 (zh) 1999-04-30

Family

ID=10770811

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98107193A HK1007957A1 (zh) 1995-03-03 1998-06-27 液狀藥用合劑藻酸鹽和重碳酸鉀

Country Status (22)

Country Link
US (1) US5681827A (cs)
EP (1) EP0813407B1 (cs)
JP (1) JPH11501044A (cs)
KR (1) KR19980702689A (cs)
CN (1) CN1123337C (cs)
AR (1) AR004168A1 (cs)
AT (1) ATE218853T1 (cs)
AU (1) AU696480B2 (cs)
BR (2) BR9607679B8 (cs)
CZ (1) CZ289386B6 (cs)
DE (1) DE69621785T2 (cs)
ES (1) ES2174054T3 (cs)
GB (1) GB9504599D0 (cs)
HK (1) HK1007957A1 (cs)
HU (1) HUP9801414A3 (cs)
NO (1) NO316207B1 (cs)
NZ (1) NZ301749A (cs)
PL (1) PL184245B1 (cs)
PT (1) PT813407E (cs)
TR (1) TR199700891T1 (cs)
WO (1) WO1996027368A1 (cs)
ZA (1) ZA961517B (cs)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6099871A (en) * 1995-06-01 2000-08-08 Bristol-Myers Squibb Company Anti-regurgitation infant formula
PL195410B1 (pl) * 1997-04-30 2007-09-28 Reckitt Benckiser Healthcare Zastosowanie kompozycji farmaceutycznej zawierającej alginian sodu do wytwarzania leku
US6027715A (en) * 1998-03-02 2000-02-22 Pozuelo; Jose Composition and means for treating dry mouth
AU4759099A (en) * 1998-09-21 2000-03-23 Mcneil-Ppc, Inc. Heat stable antacid and antigas suspensions
JP3959192B2 (ja) * 1998-12-03 2007-08-15 株式会社大塚製薬工場 経管栄養食品
US6351665B1 (en) 1999-05-07 2002-02-26 Kenneth L Koch Method and apparatus for evaluating myoelectric signals and identifying artifact
GB2384986B (en) * 2002-02-12 2004-01-07 Reckitt Benckiser Healthcare Compositions for the treatment of disorders of the upper gastrointestinal tract
SE530184C2 (sv) * 2005-12-23 2008-03-18 Kjell Stenberg Bioadhesiv farmaceutisk filmkomposition innehållande lågviskösa alginater
CN101442982B (zh) * 2006-03-16 2012-07-18 格莱克劳吉克有限公司 用于诱导饱满感的包含优选处理过的淀粉的胃漂浮物组合物
BRPI0807982A8 (pt) 2007-02-13 2017-12-26 S Biotek Holding Aps Produto dietético compreendendo alginato
WO2008106646A2 (en) * 2007-03-01 2008-09-04 Introgen Therapeutics, Inc Methods and formulations for topical gene therapy
KR100930809B1 (ko) * 2008-02-13 2009-12-09 (주)포테이토밸리 레드킹밸리 감자의 생즙 또는 전분을 유효성분으로함유하는 위염, 위궤양 및 십이지장궤양 예방 및 치료용약학조성물
WO2010108494A1 (en) * 2009-03-25 2010-09-30 S-Biotek Holding Aps Dayspepsia treatment with alginate
KR20120108218A (ko) * 2011-03-23 2012-10-05 동아제약주식회사 위식도 역류질환 치료용 액상 타입 조성물
WO2013055251A1 (ru) * 2011-10-14 2013-04-18 Общество С Ограниченной Ответственностью "Цитонир" Пероральная фармацевтическая композиция для лечения воспалительных заболеваний желудочно-кишечного тракта
LT2806880T (lt) * 2012-01-27 2017-08-25 Institute Of Bioorganic Chemistry Farmacinė kompozicija, kaip substancija antacidiniam vaistui nuo refliukso
US9636360B2 (en) 2012-09-18 2017-05-02 pH Science Holdings, Inc Method and composition for treating gastro-esophageal disorders
KR102303835B1 (ko) * 2014-01-08 2021-09-16 영진약품 주식회사 수성의 유동성 액체 조성물 및 이의 제조방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1524740A (en) * 1976-11-09 1978-09-13 Reckitt & Colmann Prod Ltd Pharmaceutical compositions for use in the suppression of gastric reflux
US4869902A (en) * 1984-04-19 1989-09-26 Rorer Pharmaceutical Corporation Antacid composition
AU578690B2 (en) * 1984-04-19 1988-11-03 Rorer International (Overseas) Inc. Antacid composition
GB8618847D0 (en) * 1986-08-01 1986-09-10 Smith Kline French Lab Pharmaceutical formulations
DK179687D0 (da) * 1987-04-08 1987-04-08 Farma Food As Praeparat
CA1327748C (en) * 1988-09-20 1994-03-15 Christopher William Quirk Pharmaceutical composition containing ranitidine and alginic acid

Also Published As

Publication number Publication date
WO1996027368A1 (en) 1996-09-12
GB9504599D0 (en) 1995-04-26
NO973964D0 (no) 1997-08-28
CN1123337C (zh) 2003-10-08
NO316207B1 (no) 2003-12-29
MX9706661A (es) 1997-11-29
CZ274997A3 (cs) 1998-03-18
BR9607679A (pt) 1998-07-07
HUP9801414A3 (en) 2001-04-28
TR199700891T1 (xx) 1998-02-21
JPH11501044A (ja) 1999-01-26
PT813407E (pt) 2002-10-31
ATE218853T1 (de) 2002-06-15
NO973964L (no) 1997-08-28
CZ289386B6 (cs) 2002-01-16
AU696480B2 (en) 1998-09-10
NZ301749A (en) 1998-05-27
BR9607679B8 (pt) 2014-11-18
DE69621785T2 (de) 2002-11-28
US5681827A (en) 1997-10-28
CN1177292A (zh) 1998-03-25
DE69621785D1 (de) 2002-07-18
KR19980702689A (ko) 1998-08-05
ES2174054T3 (es) 2002-11-01
EP0813407A1 (en) 1997-12-29
AU4724496A (en) 1996-09-23
ZA961517B (en) 1996-09-03
EP0813407B1 (en) 2002-06-12
HUP9801414A2 (hu) 1999-01-28
AR004168A1 (es) 1998-11-04
PL322044A1 (en) 1998-01-05
PL184245B1 (pl) 2002-09-30

Similar Documents

Publication Publication Date Title
HK1007957A1 (zh) 液狀藥用合劑藻酸鹽和重碳酸鉀
ES2155578T3 (es) Mejoras en o en relacion con la aglomeracion de almidon.
AU5925296A (en) Relaxin analogs and derivatives methods and uses thereof
IL124268A (en) Hypocholesterolemic (1-aryl-2-oxo-3-substituted-4-azetidinyl) phenylglucopyranose derivatives and pharmaceutical compositions containing them
AU8465591A (en) Gas and liquid contact body
AU8016694A (en) Determination of genomic sex in salmonids
AU3684895A (en) Use of human chorionic gonadotropin as an immune-potentiating agent
HK1007957B (en) A liquid pharmaceutical composition alginate and potassium bicarbonate
HUP9801356A3 (en) Triciclic (2-hydroxy-2-methyl-3,3,3-trifluoropropanoyl)-amino-benzoxepine, -benzothiepine, -benzocycloheptene, -indene derivatives and pharmaceutical compositions containing them
HUP9700005A3 (en) 2-ureido-benzamide derivatives and pharmaceutical compositions containing them as active agent
AU5637796A (en) Human leukocyte 12-lipoxygenase and its role in the pathogenesis of disease states
AU5015396A (en) Thiazole and thiadiazole derivatives, their preparation and pharmaceutical compositions useful in the treatment of throm bocytopenia
HUP9901336A3 (en) Heteroaryl-substituted acryloylguanidine derivatives and medicinal composition thereof
AU5317390A (en) Concentrated aqueous solution of glutaraldehyde and 1,2-benzisothiazolin-3-one
AU1368497A (en) New aqueous swellable compositions of guar gum and guar gum derivatives in oleophilic liquids and their use
AU4985596A (en) Novel aroylaniline derivatives, compositions and uses thereof in the treatment of viral infections
AU624617B2 (en) Sodium chloride in novel crystal form and aqueous solution containing the same
GB2298365B (en) A liquid pharmaceutical composition alginate and potassium bicarbonate
ZA967536B (en) Electrochemical preparation of sodium and aluminium chloride.
CA2214343A1 (en) Liquid aqueous pharmaceutical compositions comprising sodium alginate and potassium bicarbonate
AU1064995A (en) Derivatives of 2,3,5,6-tetrafluorobenzoic acid and their use in combating pests
AU5148896A (en) Hydrazonoacetic acid amides and the use thereof as pesticide s
AU3854597A (en) 1-azoniabicyclo{2.2.1}heptane derivatives and pharmaceutical compositions containing them
AU7340696A (en) Sulfoxide derivatives of nitrogen-mustard and anticancer agent containing the same
ZA959919B (en) The administration of magnesium and/or potassium and amino acids

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20140227